Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 single-arm study of 3% diquafosol sodium eye drops in dry eye
ChiCTR1900021999Phase 4Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diquafosol in dry eye syndrome (DED), sponsored by Beijing Tongren Hospital. Primary endpoint: Corneal fluorescein staining at 1 month. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
diquafosol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR1900021999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021999.